PHARMACOKINETICS OF PROSTAGLANDIN E1 AND ITS MAIN METABOLITES AFTER INTRACAVERNOUS INJECTION AND SHORT-TERM INFUSION OF PROSTAGLANDIN E1 IN PATIENTS WITH ERECTILE DYSFUNCTION-Reference-Cited by-同舟云学术

PHARMACOKINETICS OF PROSTAGLANDIN E1 AND ITS MAIN METABOLITES AFTER INTRACAVERNOUS INJECTION AND SHORT-TERM INFUSION OF PROSTAGLANDIN E1 IN PATIENTS WITH ERECTILE DYSFUNCTION

Published:1997-10 Issue:4 Volume:158 Page:1403-1407
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Cawello Willi¹,Schweer Horst¹,Dietrich Bruno¹,Seyberth Hannsjorg Wilhelm¹,Albrecht Detlef¹,Fox Alanna¹,Hohmuth Horst¹

Affiliation:

1. From the Schwarz Pharma AG, Monheim am Rhein, Childrens Hospital, University of Marburg, Marburg, L.A.B. GmbH & Co, Neu-Ulm, and Urological Office, Ulm, Germany.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference17 articles.

1. Studies on male sexual impotence. Report 18. Therapeutic trial with prostaglandin E1 for organic impotence;Ishii;Nippon Hinyokika Gakkai Zasshi,1986

2. Intracavernous injection of prostaglandin E1 in impotent men.;Stackl;J. Urol.,1988

3. Intracavernous self-injection of prostaglandin E1 in the therapy of erectile dysfunction.;Porst;VASA,1989

4. Dose-dependent effect and side-effect of prostaglandin E1 in erectile dysfunction.;Schramek;Brit. J. Clin. Pharmacol.,1989

5. Pharmacological erection program using prostaglandin E1.;Gerber;J. Urol.,1991

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prostaglandin E1 Inhibits GLI2 Amplification–Associated Activation of the Hedgehog Pathway and Drug Refractory Tumor Growth;Cancer Research;2020-05-05

2. Development of a novel topical formulation of glyceryl trinitrate for the treatment of erectile dysfunction;International Journal of Impotence Research;2020-01-31

3. Development, Optimization, and Characterization of PEGylated Nanoemulsion of Prostaglandin E1 for Long Circulation;AAPS PharmSciTech;2015-07-21

4. Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery;Therapeutic Delivery;2013-10

5. Erectile Dysfunction Management for the Future;Journal of Andrology;2008-09-18